Related Experiment Video
Updated: Sep 30, 2026

Mapping Hepatic Stellate Cell Morphology in Mouse Models of Liver Fibrosis
Published on: February 13, 2026
Rat liver myofibroblasts and hepatic stellate cells differ in CD95-mediated apoptosis and response to TNF-alpha
Bernhard Saile1, Nina Matthes, Katrin Neubauer
1Department of Internal Medicine, Section of Gastroenterology and Endocrinology, University of Göttingen, Germany.
Abstract:
Hepatic stellate cells (HSC), particularly activated HSC, are thought to be the principle matrix-producing cell of the diseased liver. However, other cell types of the fibroblast lineage, especially the rat liver myofibroblasts (rMF), also have fibrogenic potential. A major difference between the two cell types is the different life span under culture conditions. Although nearly no spontaneous apoptosis could be shown in rMF cultures, 18 +/- 2% of the activated HSC (day 7) were apoptotic. Compared with activated HSC, CD95R was expressed in 70% higher amounts in rMF. CD95L could only be detected in activated HSC. Stimulation of the CD95 system by agonistic antibodies (1 ng/ml) led to apoptosis of all rMF within 2 h, whereas activated HSC were more resistant (5.3 h/ 40% of total cells). Although transforming growth factor-beta downregulated apoptosis in both activated HSC and rMF, tumor necrosis factor-alpha (TNF-alpha) upregulated apoptosis in rMF. Lack of spontaneous apoptosis and CD95L expression in rMF and the different reaction on TNF-alpha stimulation reveal that activated HSC and rMF belong to different cell populations.
Insights
Rat liver myofibroblasts (rMF) and activated hepatic stellate cells (HSC) differ significantly. rMF show less apoptosis and distinct CD95 system responses, indicating they are separate cell populations with fibrogenic potential.
Area of Science:
- Cell Biology
- Hepatology
- Fibrosis Research
Background:
- Activated hepatic stellate cells (HSC) are primary matrix producers in liver disease.
- Rat liver myofibroblasts (rMF) also possess fibrogenic potential.
- Differences in lifespan and apoptosis exist between activated HSC and rMF in culture.
Purpose of the Study:
- To investigate and compare the characteristics of activated HSC and rMF.
- To elucidate the role of the CD95 system in the apoptosis of these cell types.
- To determine the differential responses of activated HSC and rMF to apoptosis-inducing stimuli.
Main Methods:
- Cell culture of activated HSC and rMF.
- Assessment of spontaneous apoptosis rates.
- Quantification of CD95 receptor (CD95R) and ligand (CD95L) expression.
- Induction of apoptosis using agonistic antibodies against CD95.
- Evaluation of apoptosis in response to transforming growth factor-beta and tumor necrosis factor-alpha (TNF-alpha).
Main Results:
- rMF exhibited minimal spontaneous apoptosis, while activated HSC showed significant apoptosis (18%).
- rMF expressed 70% more CD95R than activated HSC; CD95L was detected only in activated HSC.
- CD95 system stimulation induced rapid apoptosis in rMF (2h) but slower apoptosis in activated HSC (5.3h, 40%).
- Transforming growth factor-beta reduced apoptosis in both cell types.
- Tumor necrosis factor-alpha upregulated apoptosis specifically in rMF.
Conclusions:
- Activated HSC and rMF represent distinct cell populations.
- Differential expression of CD95 components and varied responses to TNF-alpha support their classification as separate cell types.
- These findings have implications for understanding liver fibrogenesis and therapeutic targeting.
Related Concept Videos
Liver Regeneration
Cells of Liver
The liver comprises four major types of cells— hepatocytes, stellate, Kupffer, and sinusoidal endothelial cells. The hepatocytes are large...
Cirrhosis II: Pathophysiology
T Cell Types and Functions
Th1 cells stimulate dendritic cells to express necessary co-stimulatory molecules on their surfaces for...
Cirrhosis I: Introduction

